Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07226310 · ClinicalTrials.gov registry record · Early Phase 1
The Hysterosalpingogram (HSG) Experience And Tubal Spasm (HEAT) Study
A Early Phase 1 study of Infertility, sponsored by University of Oklahoma.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT07226310 is a Early Phase 1 study of Infertility that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 240 participants, below the 7,586-participant average among 74 other Infertility trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07226310, a Early Phase 1 study of Infertility, is actively recruiting participants, sponsored by University of Oklahoma.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
The hysterosalpingogram (HSG) is the gold standard of assessing fallopian tube patency and involves the placement of a transcervical catheter to allow for instillation of radio-opaque dye into the uterine cavity and fallopian tubes which are then imaged with abdominal x-ray. A common side effect of the instillation of dye is the uterine cramping, which is both uncomfortable for the patient as well as can cause iatrogenic proximal occlusion of the fallopian tubes. Proximal tubal obstruction is often not representative of true tubal obstruction but is rather an artifact of the test. Prior studies measuring the perceived pain and cramping during HSG have been conducted which have shown reduced pain scores and decreased uterine cramping when warmed contrast dye is used. The researchers propose that the use of warmed contrast media during HSG will be correlated with decreased pain scores and fewer cases of proximal tubal occlusion in women with otherwise normal uterine anatomy.
Conditions Studied
Interventions
- DRUG Warmed HSG
Study Locations (1)
Oklahoma
- University of Oklahoma Health Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2026-03 |
| Est. Completion | 2026-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07226310
The ClinicalTrials.gov registry entry for NCT07226310 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,586-participant average among 74 other Infertility trials with a reported enrollment target (97% lower). The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 1 intervention - of which Warmed HSG is the first listed.
NCT07226310 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.
Frequently Asked Questions
What is clinical trial NCT07226310 about?
NCT07226310 is a clinical study titled "The Hysterosalpingogram (HSG) Experience And Tubal Spasm (HEAT) Study". The hysterosalpingogram (HSG) is the gold standard of assessing fallopian tube patency and involves the placement of a transcervical catheter to allow for instillation of radio-opaque dye into the uterine cavity and fallopian tubes which are then imaged with abdominal x-ray. A common side effect of ...
What is the current status of trial NCT07226310?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 240 participants. The study started on 2026-03. Estimated completion is 2026-12.
What conditions does trial NCT07226310 study?
This clinical trial studies the following conditions: Infertility.
What interventions are being tested in trial NCT07226310?
The interventions under investigation include: Warmed HSG (DRUG).
Who is sponsoring clinical trial NCT07226310?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07226310 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
-
Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
RECRUITING · Phase 1
-
Non-Euploid Embryo Transfer (NEET) Registry
RECRUITING
-
Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield
RECRUITING · NA
-
Apple Women's Health Study
RECRUITING
-
Discarded Materials Study
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.